Acadia Pharmaceuticals Inc.
ACAD-Q

1 watching
Join the Discussion
Comment Now

Acadia Pharmaceuticals Inc. (ACAD-Q)

SAVE
25.54
1.31 (5.41%)

About Acadia Pharmaceuticals Inc. (ACAD-Q)

ACADIA Pharmaceuticals, Inc. is a biopharmaceutical company. The company has a portfolio of four product candidates, including pimavanserin, which is in Phase IV development as a treatment for Parkinson's disease psychosis. More at Wikipedia